PLAIAR-Trial: Platelets in Inflammation and Resolution
NCT05098106 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 72
Last updated 2021-11-10
Summary
Detection and determination of platelets in bronchoalveolar lavage fluid and blood in ARDS and non-ARDS-patients. Correlation with phenotype and inflammation parameters in blood and outcome parameters.
Conditions
- ARDS
- Platelet Abnormality
Interventions
- DIAGNOSTIC_TEST
-
Bronchoscopy, blood sampling; testing.
BAL and blood samples are measured by hematology analyzer, flow cytometry, western blot, RNAseq analysis and multiplex.
Sponsors & Collaborators
-
Study Chair and Principal Investigator: Univ.-Prof. Dr. Alexander Zarbock
collaborator UNKNOWN -
Principal Investigator: Dr. Andreas Margraf
collaborator UNKNOWN -
University Hospital Muenster
lead OTHER
Principal Investigators
-
Alexander Zarbock, Univ.-Prof. Dr. · University Hospital Muenster
-
Andreas Margraf, Dr. · University Hospital Muenster
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-05-01
- Primary Completion
- 2023-03-31
- Completion
- 2023-03-31
Countries
- Germany
Study Locations
More Related Trials
-
PLASMA Trial: A Dose-Response Study of A-002 In Subjects With Stable Coronary Artery Disease
NCT00455546 ·Status: COMPLETED ·Phase: PHASE2
-
Study Effect of VIA-2291 on Vascular Inflammation
NCT00358826 ·Status: COMPLETED ·Phase: PHASE2
-
Platelet PAR-1 Activation in Health and Diabetes
NCT04280549 ·Status: COMPLETED
-
Alirocumab in Patients with Sepsis
NCT05469347 ·Status: COMPLETED ·Phase: PHASE1
-
Study Effect of VIA-2291 on Atherosclerotic Vascular Inflammation in Patients Undergoing Elective Carotid Endarterectomy
NCT00352417 ·Status: COMPLETED ·Phase: PHASE2
-
Double-Blind, Multicenter, Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19
NCT04389450 ·Status: TERMINATED ·Phase: PHASE2
-
The Impact of Factor Xa Inhibition on Thrombosis, Platelet Activation, and Endothelial Function in Peripheral Artery Disease
NCT05009862 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, Tolerability, and Biodistribution of [89Zr]Zr-DFO-APAC in Subjects With PAOD/CLI and Healthy Volunteers (Acronyms: 89Zr = Zirconium-89, DFO = Desferrioxamine, APAC = AntiPlatelet AntiCoagulant, PET/CT = Positron Emission Tomography/Computed Tomography)
NCT06204237 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Carotid Plaque Regression With Statin Treatment Assessed by High Field Magnetic Resonance Imaging (MRI)
NCT00388843 ·Status: WITHDRAWN
-
Effect of APL180 on Endothelial Function in Familial Hypercholesterolemia Patients
NCT00751608 ·Status: WITHDRAWN ·Phase: PHASE2
-
Carotid Atherosclerotic Plaque Study
NCT00214006 ·Status: COMPLETED
-
PLASMA 2 Trial: Examination of Once Daily (QD) Dosing of A-002 In Subjects With Stable Coronary Artery Disease
NCT00525954 ·Status: COMPLETED ·Phase: PHASE2
-
Phosphorylcholine PC-mAb Effects in Subjects With Elevated Lipoprotein a
NCT03320265 ·Status: TERMINATED ·Phase: PHASE2
-
Study of microRNAs in the Evolution of Carotid Plaque. Physiopathological and Therapeutic Interest
NCT03149406 ·Status: UNKNOWN
-
A Single Ascending Dose Study Examining the Safety and Pharmacokinetic Profile of Reconstituted High Density Lipoprotein (CSL112) Administered to Patients
NCT01499420 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation on the Effect of Smoking on the Expression of Pro- and Anti-thrombotic, Anti-oxidative, and Inflammatory Markers in Humans
NCT02198937 ·Status: TERMINATED
-
The DIEP Flap as a Model of Ischemia-Reperfusion: an Intervention Study
NCT00821158 ·Status: UNKNOWN ·Phase: PHASE3
-
Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease
NCT03304821 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Rosiglitazone Anti-inflammatory Effect With FDG-PET Imaging
NCT01174056 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Treatment of PAD by Platelet Lysate for Therapeutic Angiogenesis
NCT02941419 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety Study of PZ-128 in Subjects With Multiple Coronary Artery Disease Risk Factors
NCT01806077 ·Status: COMPLETED ·Phase: PHASE1
-
SDF1 Plasmid Treatment for Patients With Peripheral Artery Disease
NCT02544204 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of LLG783 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication
NCT03194776 ·Status: COMPLETED ·Phase: PHASE2
-
Cilostazol After Lower Extremity Arterial Revascularization Trial
NCT02374957 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy, Tolerability and Safety of Intramuscular Injections of PLX PAD for the Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for Revascularization
NCT03006770 ·Status: COMPLETED ·Phase: PHASE3